Previous 10 | Next 10 |
The following slide deck was published by Sesen Bio, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Sesen Bio, Inc. (SESN) Q3 2019 Earnings Conference Call November 12, 2019, 8:00 am ET Company Participants Chad Myskiw - Senior Director, Strategic Planning Thomas Cannell - President & CEO Monica Forbes - CFO Conference Call Participants John Newman - Canaccord Roger...
Sesen Bio (NASDAQ: SESN ): Q3 GAAP EPS of -$0.13 misses by $0.04 . Cash and cash equivalents of $57.8M Shares +2.7% Press Release More news on: Sesen Bio, Inc., Earnings news and commentary, Healthcare stocks news, ,
On Track for Anticipated Initiation of BLA Submission in December, 2019 Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported financial results for the third quarter of 201...
Orion Energy Systems OESX +24% on Q2 results . More news on: Agile Therapeutics, Inc., Sesen Bio, Inc., Stocks on the move, Read more ...
Alignment reached with FDA on post-marketing confirmatory trial design Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported alignment with the FDA on the design of its pos...
Cyclerion Therapeutics CYCN -70% on failed praliciguat studies . More news on: Navidea Biopharmaceuticals, Inc., Sesen Bio, Inc., IVERIC bio, Inc., Stocks on the move, Read more ...
Company to Host Conference Call to Provide Business Update on November 12, 2019 at 8 a.m. EST Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported modifications to its 2...
Gainers: Lightbridge Corporation (NASDAQ: LTBR ) +19% . Sesen Bio (NASDAQ: SESN ) +17% . Visteon Corporation (NASDAQ: VC ) +17% . Tesla (NASDAQ: TSLA ) +17% . Rigel Pharmaceuticals (NASDAQ: RIGL ) +17% . TrovaGene (NASDAQ: TROV ) +16% . Contango Oil & Gas Company (NYSEMKT: ...
Carl Icahn controlled ENZN to date has been a multi-year, slow motion liquidation story. Enzon has been regularly paying out royalty and milestone revenue as dividends since the company shrunk to a shell back in 2013/2014. The company recently paid a 12 cent dividend, having closed at 25.7 c...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...